Compare Open Text Corporation (OTEX) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Open Text Corporation vs Repligen Corporation Common Stock — how do they compare? Open Text Corporation trades at $24.97 (market cap $6.05B), while Repligen Corporation Common Stock trades at $178.85 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is the larger of the two by market cap, and Open Text Corporation pays a 4.48% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Open Text Corporation for 24 Days and Repligen Corporation Common Stock for 0 Days on average.
| OTEX | RGEN | |
|---|---|---|
Market Cap | $6.05B | $11.31B |
Volume | 1,438,319 | 1,216,919 |
Sector | Technology | Health |
52-Week High | $39.69 | $194.57 |
52-Week Low | $20.01 | $102.87 |
Typical Hold Time | 24 Days | 0 Days |
Enterprise Value | $11.07B | $11.20B |
Dividend Yield | 4.48% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OpenText (OTEX) trades at $24.95, up 3.18% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock's valuation appears attractive with a P/E of 9.68 and P/S of 1.19, while profitability metrics like a 73.74% gross margin and 16.19% ROE are robust. Recent corporate actions include a $1.0 billion senior secured notes offering and a partnership with Cohere to advance AI capabilities, signaling strategic debt management and growth initiatives.
The outlook is positive given improving fundamentals and analyst consensus, but risks include high debt levels and competitive pressures. The consensus price target of $28.30 suggests upside potential, supported by cloud revenue growth and cost discipline. Investors should weigh the discounted valuation against execution risks in a dynamic software market.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
